Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Showing 1-25 of 30 citing articles:

Correlates of protection against COVID-19 infection and intensity of symptomatic disease in vaccinated individuals exposed to SARS-CoV-2 in households in Israel (ICoFS): a prospective cohort study
Gili Regev‐Yochay, Yaniv Lustig, Gili Joseph, et al.
The Lancet Microbe (2023) Vol. 4, Iss. 5, pp. e309-e318
Open Access | Times Cited: 66
Significance of Conserved Regions in Coronavirus Spike Protein for Developing a Novel Vaccine against SARS-CoV-2 Infection
Titus Abiola Olukitibi, Zhujun Ao, Bryce M. Warner, et al.
Vaccines (2023) Vol. 11, Iss. 3, pp. 545-545
Open Access | Times Cited: 21
Long-term durability of immune responses to the BNT162b2 and mRNA-1273 vaccines based on dosage, age and sex
Chapin S. Korosec, Suzan Farhang‐Sardroodi, David W. Dick, et al.
Scientific Reports (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 34
Monkeypox: a review of epidemiological modelling studies and how modelling has led to mechanistic insight
Marina Banuet-Martínez, Yang Yang, Behnaz Jafari, et al.
Epidemiology and Infection (2023) Vol. 151
Open Access | Times Cited: 15
Immunogenicity of COVID-19 vaccines and their effect on HIV reservoir in older people with HIV
Vitaliy Matveev, Erik Z. Mihelic, Erika Benko, et al.
iScience (2023) Vol. 26, Iss. 10, pp. 107915-107915
Open Access | Times Cited: 15
SARS-CoV-2 booster vaccine dose significantly extends humoral immune response half-life beyond the primary series
Chapin S. Korosec, David W. Dick, Iain R. Moyles, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 6
mRNA vaccine-induced SARS-CoV-2 spike-specific IFN-γ and IL-2 T-cell responses are predictive of serological neutralization and are transiently enhanced by pre-existing cross-reactive immunity
Philip Samaan, Chapin S. Korosec, Patrick Budylowski, et al.
Journal of Virology (2025)
Open Access
Autoimmunity and Immunodeficiency in Severe SARS-CoV-2 Infection and Prolonged COVID-19
Jenny Garmendia, Alexis García, Claudia Valentina De Sanctis, et al.
Current Issues in Molecular Biology (2022) Vol. 45, Iss. 1, pp. 33-50
Open Access | Times Cited: 24
Multiple cohort study of hospitalized SARS-CoV-2 in-host infection dynamics: Parameter estimates, identifiability, sensitivity and the eclipse phase profile
Chapin S. Korosec, Matthew Betti, David W. Dick, et al.
Journal of Theoretical Biology (2023) Vol. 564, pp. 111449-111449
Open Access | Times Cited: 10
Determination of significant immunological timescales from mRNA-LNP-based vaccines in humans
Iain R. Moyles, Chapin S. Korosec, Jane M. Heffernan
Journal of Mathematical Biology (2023) Vol. 86, Iss. 5
Open Access | Times Cited: 10
A Broad-Spectrum Multi-Antigen mRNA/LNP-Based Pan-Coronavirus Vaccine Induced Potent Cross-Protective Immunity Against Infection and Disease Caused by Highly Pathogenic and Heavily Spike-Mutated SARS-CoV-2 Variants of Concern in the Syrian Hamster Model
Swayam Prakash, Nisha R. Dhanushkodi, Mahmoud Singer, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 3
Intravenous BCG vaccination reduces SARS-CoV-2 severity and promotes extensive reprogramming of lung immune cells
Alok Kumar Singh, Rulin Wang, Kara A. Lombardo, et al.
iScience (2023) Vol. 26, Iss. 10, pp. 107733-107733
Open Access | Times Cited: 9
SARS-CoV-2 T Cell Immunity Responses following Natural Infection and Vaccination
Vassiliki Pitiriga, Myrto Papamentzelopoulou, Kanella E. Konstantinakou, et al.
Vaccines (2023) Vol. 11, Iss. 7, pp. 1186-1186
Open Access | Times Cited: 8
High‐resolution analysis of individual spike peptide‐specific CD4+ T‐cell responses in vaccine recipients and COVID‐19 patients
Hendrik Karsten, Leon Cords, Tim Westphal, et al.
Clinical & Translational Immunology (2022) Vol. 11, Iss. 8
Open Access | Times Cited: 12
Significance of Conserved Regions in Coronavirus Spike Protein for Developing a Novel Vaccine against SARS-Cov-2 Infection
Titus Abiola Olukitibi, Zhujun Ao, Bryce M. Warner, et al.
(2023)
Open Access | Times Cited: 7
Considerations for Choosing T Cell Assays during a Pandemic
Jaclyn C. Law, Tania H. Watts
The Journal of Immunology (2023) Vol. 211, Iss. 2, pp. 169-174
Closed Access | Times Cited: 7
Within-host evolution of SARS-CoV-2: how often are de novo mutations transmitted from symptomatic infections?
Chapin S. Korosec, Lindi M. Wahl, Jane M. Heffernan
Virus Evolution (2024) Vol. 10, Iss. 1
Open Access | Times Cited: 2
Breadth and Durability of SARS-CoV-2-Specific T Cell Responses following Long-Term Recovery from COVID-19
Thi Thu Thao Dang, Alitzel Anzurez, Kaori Nakayama‐Hosoya, et al.
Microbiology Spectrum (2023) Vol. 11, Iss. 4
Open Access | Times Cited: 5
SARS-CoV-2 Humoral and Cellular Immune Responses in HIV-Positive Patients
Simona Ruţă, Corneliu Petru Popescu, Lilia Matei, et al.
(2024)
Open Access | Times Cited: 1
Optimal vaccination policy to prevent endemicity: a stochastic model
Félix Foutel‐Rodier, Arthur Charpentier, Hélène Guérin
Journal of Mathematical Biology (2024) Vol. 90, Iss. 1
Open Access | Times Cited: 1
Identification of pre-infection markers and differential plasma protein expression following SARS-CoV-2 infection in people living with HIV
Márton Kolossváry, Christopher R. deFilippi, Sara McCallum, et al.
EBioMedicine (2023) Vol. 90, pp. 104538-104538
Open Access | Times Cited: 3
Monkeypox: A review of epidemiological modelling studies and how modelling has led to mechanistic insight
Chapin S. Korosec, Marina Banuet-Martínez, Yang Yang, et al.
Research Square (Research Square) (2023)
Open Access | Times Cited: 2
Immunogenicity of COVID-19 vaccines and their effect on the HIV reservoir in older people with HIV
Vitaliy Matveev, Erik Z. Mihelic, Erika Benko, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 2
SARS-CoV-2 booster vaccine dose significantly extends humoral immune response half-life beyond the primary series
Chapin S. Korosec, David W. Dick, Iain R. Moyles, et al.
medRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
mRNA Vaccine-Induced SARS-CoV-2 Spike-Specific IFN-γ and IL-2 T-cell Responses are Predictive of Serological Neutralization and are Transiently Enhanced by Pre-Existing Cross-Reactive Immunity
Philip Samaan, Chapin S. Korosec, Patrick Budylowski, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Page 1 - Next Page

Scroll to top